Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Amgen
Amgen
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Fierce Pharma
Fri, 05/16/25 - 11:40 am
Amgen
Regeneron
PCSK9
legal
antitrust
Praluent
Repatha
Amgen’s Stelara biosimilar gets off to fast start
BioPharma Dive
Sun, 05/4/25 - 12:00 pm
Amgen
Stelara
biosimilars
JNJ
FDA frees Amgen's phase 1 obesity asset from clinical trial hold
Fierce Biotech
Fri, 05/2/25 - 11:18 am
FDA
Amgen
obesity
clinical trials
AMG 513
Amgen posts profit, says tax policy more effective than tariffs
Investing.com
Fri, 05/2/25 - 10:55 am
Amgen
earnings
tariffs
Amgen Strengthens US Biomanufacturing with $900M Ohio Investment
Xtalks
Wed, 04/30/25 - 11:10 am
Amgen
drug manufacturing
Ohio
Sandoz files U.S. antitrust lawsuit against Amgen over arthritis drug
Investing.com
Mon, 04/14/25 - 09:42 am
Sandoz
antitrust
legal
Amgen
Enbrel
generics
Amgen pads Imdelltra's case in tough-to-treat lung cancer subtype with phase 3 survival win
Fierce Pharma
Sun, 04/13/25 - 11:21 pm
Amgen
Imdelltra
extensive-stage small cell lung cancer
clinical trials
Why Amgen Hired An AI Head From Nike
Forbes
Fri, 04/11/25 - 11:30 am
Amgen
artificial intelligence
Amgen stock rises following FDA approval of Uplinza
Investing.com
Thu, 04/3/25 - 10:18 pm
Amgen
Uplinza
FDA
immunoglobulin G4-related disease
How AZ and Amgen’s Tezspire respiratory data ups the ‘level of ambition’ in immunology
Pharma Voice
Thu, 03/27/25 - 11:06 am
Amgen
AstraZeneca
nasal polyps
Tezspire
chronic rhinosinusitis with nasal polyps
Amgen’s Uplizna deepens response against myasthenia gravis at 1 year
BioSpace
Thu, 03/13/25 - 11:28 am
Amgen
Uplinza
myasthenia gravis
Amgen and Kyowa Kirin’s rocatinlimab trial for atopic dermatitis meets endpoints
Clinical Trials Arena
Mon, 03/10/25 - 09:34 am
Amgen
Kyowa Kirin
clinical trials
rocatinlimab
atopic dermatitis
Amgen and CytomX throw off masked T-cell engager, axing asset after assessing data, priorities
Fierce Biotech
Fri, 03/7/25 - 11:09 am
Amgen
CytomX Therapeutics
T-cell engager
CX-904
Amgen enters Maritime, launching 2 late-stage obesity trials for MariTide
Fierce Biotech
Wed, 03/5/25 - 10:58 pm
Amgen
MariTide
clinical trials
obesity
With patent losses on the horizon, Amgen refocuses its business strategy
Pharma Voice
Wed, 03/5/25 - 11:53 am
Amgen
restructuring
Amgen and AstraZeneca report results from Phase III trial of Tezspire for CRSwNP
Clinical Trials Arena
Mon, 03/3/25 - 10:19 am
Amgen
AstraZeneca
clinical trials
Tezspire
chronic rhinosinusitis with nasal polyps
Amgen plans $200M investment in India site
Tip Ranks
Mon, 02/24/25 - 09:59 am
Amgen
India
Amgen ends Ideaya cancer combination trial after partner unveils rival molecule
Fierce Biotech
Thu, 02/13/25 - 09:45 pm
Amgen
IDEAYA Biosciences
AMG 193
cancer
With recent launches and more to come, Amgen's biosimilar business is trending up
Fierce Pharma
Thu, 02/6/25 - 11:43 am
Amgen
biosimilars
Amgen's early-stage obesity asset slapped with FDA hold
Fierce Biotech
Wed, 02/5/25 - 11:27 am
Amgen
FDA
clinical trials
obesity
AMG 513
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »